{"entity":{"type":"insider","cik":"0001808290","url":"/insider/0001808290","json_url":"/insider/0001808290.json","name":"Ordonez Claudia","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":5,"first":"2021-02-16","last":"2021-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Ordonez Claudia","source":"filing","n_filings":5,"first_seen":"2021-02-16","last_seen":"2021-06-15"}],"transactions":[{"id":5529261,"accession":"0001209191-21-040648","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-040648","line_url":"/filing/0001209191-21-040648","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808290","owner_name":"Ordonez Claudia","owner_display_name":"Ordonez Claudia","owner_url":"/insider/0001808290","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":50.99009,"price_display":"50.99","price_state":"stated","total_value":50990.09,"total_display":"50,990.09","total_whole":"50,990","shares_owned_after":347.0,"shares_owned_after_display":"347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-15","scope":"insider","n_lines":2},{"id":5100192,"accession":"0001209191-21-032361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032361","line_url":"/filing/0001209191-21-032361#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808290","owner_name":"Ordonez Claudia","owner_display_name":"Ordonez Claudia","owner_url":"/insider/0001808290","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":50.15,"price_display":"50.15","price_state":"stated","total_value":50150.0,"total_display":"50,150.00","total_whole":"50,150","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":5193392,"accession":"0001209191-21-026669","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-026669","line_url":"/filing/0001209191-21-026669","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808290","owner_name":"Ordonez Claudia","owner_display_name":"Ordonez Claudia","owner_url":"/insider/0001808290","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":59.92626,"price_display":"59.93","price_state":"stated","total_value":59926.26,"total_display":"59,926.26","total_whole":"59,926","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-14","scope":"insider","n_lines":3},{"id":5374995,"accession":"0001209191-21-020483","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-020483","line_url":"/filing/0001209191-21-020483","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808290","owner_name":"Ordonez Claudia","owner_display_name":"Ordonez Claudia","owner_url":"/insider/0001808290","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":64.55585,"price_display":"64.56","price_state":"stated","total_value":64555.85,"total_display":"64,555.85","total_whole":"64,556","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-11","filed_date":"2021-03-15","scope":"insider","n_lines":2},{"id":4176979,"accession":"0001209191-21-010882","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-010882","line_url":"/filing/0001209191-21-010882","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808290","owner_name":"Ordonez Claudia","owner_display_name":"Ordonez Claudia","owner_url":"/insider/0001808290","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":64.84129,"price_display":"64.84","price_state":"stated","total_value":64841.29,"total_display":"64,841.29","total_whole":"64,841","shares_owned_after":513.0,"shares_owned_after_display":"513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001664710","name":"Keros Therapeutics, Inc.","url":"/issuer/0001664710","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2021-02-16","last_seen":"2021-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808290","retrieved_at":"2026-08-26T05:34:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}